Table 2 progression characteristics of drusen subtype.

From: Macular neovascularization in eyes with pachydrusen

  

Soft drusen

Pachydrusen

p-value

n = 46

n = 29

Mean duration of follow up, years

Mean ± SD

4.2 ± 0.7

5.0 ± 0.8

0.13

Final drusen area, mm2

Mean ± SD

7.6 ± 7.1

1.7 ± 2.9

 < 0.01

Final SQDA, mm

Mean ± SD

2.3 ± 1.1

1.1 ± 0.7

 < 0.01

Drusen area change/year, mm2/year

Mean ± SD

2.6 ± 0.9

0.4 ± 0.5

0.03

SQDA change/year, %/year

Mean ± SD

12.0 ± 8.7

2.2 ± 3.4

0.02

Incident exudative change, n (%)

n (%)

6 (13.3)

7 (24.1)

0.38

Mean time to exudative nAMD, years

Mean ± SD

3.7 (0.9)

4.5 (1.3)

0.46

nAMD subtype

Type 1 MNV

n (%)

4 (66.7)

1(14.3)

< 0.01

Type 2 MNV

n (%)

1 (16.7)

0

Type 1 and 2 MNV

n(%)

0

0

Type 3 MNV

n (%)

0

0

PCV

n (%)

1 (16.7)

6 (85.7)